GL1X · GenesisL1 explorer

MolNFT v1 · #116933 · protein

Crystal structure of human Fab CAP256-VRC26.25, a potent V1V2-directed HIV-1 broadly neutralizing antibody

5DT1 · Fab heavy chain of broadly neutralizing antibody VRC26.25: “Crystal structure of human Fab CAP256-VRC26.25, a potent V1V2-directed HIV-1 broadly neutralizing antibody”. X-ray diffraction, 2 ligands (NAG, BMA), 3 pockets (best…

PDB
5DT1
Type
protein
Length
460 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fab heavy chain of broadly neutralizing antibody VRC26.25; Fab light chain of broadly…
Ligands
NAG, BMA
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HFab heavy chain of broadly neutralizing antibody VRC26.25protein2458% helix, 53% strand—
LFab light chain of broadly neutralizing antibody VRC26.25protein2159% helix, 48% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains L
  • BMA · beta-D-mannopyranose · sugar

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17990.710.7790empty
21310.470.7824empty
3900.390.7723empty

Interfaces

1 interface between chains.

  • H–L · 1999 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 2 modified, 1 glycan (disulfide, sulfation, N-glycosylation).

Compared structures

  • 5DT1 · Crystal structure of human Fab CAP256-VRC26.25, a potent V1V2-directed HIV-1 broadly… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.